Dr. Jeng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Cente Blvd
Philadelphia, PA 19104Phone+1 667-214-1232
Education & Training
- Cleveland Clinic FoundationResidency, Ophthalmology, 1999 - 2002
- Cleveland Clinic FoundationInternship, Internal Medicine, 1998 - 1999
- Perelman School of Medicine at the University of PennsylvaniaClass of 1998
- University of California (San Francisco)Fellowship, Cornea, External Diseases, and Refractive Surgery
Certifications & Licensure
- CA State Medical License 2002 - 2026
- PA State Medical License 2022 - 2024
- MD State Medical License 2013 - 2022
- OH State Medical License 2000 - 2022
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects Start of enrollment: 2011 Nov 01
- Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients Start of enrollment: 2013 May 22
- Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA) Start of enrollment: 2021 Jul 02
Publications & Presentations
PubMed
- Recruitment Strategies and Obstacles During the Zoster Eye Disease Study.Mark D Sherman, Penny Asbell, David Warner, Shahzad I Mian, Elisabeth Cohen
Cornea. 2024-12-03 - 1 citationsBaseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study.Christina R Prescott, Elisabeth J Cohen, Judith S Hochman, Andrea B Troxel, Ying Lu
Cornea. 2024-12-01 - Corneal Transplant Rejection Postvaccination Among Medicare Beneficiaries.Muhammad Ali, Chen Dun, Gayane Yenokyan, Uri Soiberman, Bennie H Jeng
Cornea. 2024-11-01
Press Mentions
- UPenn Research: Long-Term Antiviral Use Is Key to Ocular Shingles TreatmentOctober 30th, 2024
- Research Suggests Long-Term Antiviral Use Is Key to Ocular Shingles TreatmentOctober 21st, 2024
- Long-Term Low-Dose Antiviral Treatment Reduces Eye Disease Risk from ShinglesOctober 19th, 2024
- Join now to see all
Grant Support
- A Novel Therapeutic For The Treatment Of Persistent Corneal Epithelial DefectsFood And Drug Administration2010
Professional Memberships
- Fellow
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: